Biopharmaceutical

Biopharmaceutical Research Company (BRC) is a specialty biotechnology firm focused on the research and development of cannabis-derived therapeutics. The company holds several federal licenses from the DEA to legally cultivate and analyze cannabis for medical research purposes in the United States. BRC aims to bridge the gap between the cannabis industry and the pharmaceutical sector by applying rigorous scientific standards to the study of cannabinoids. Their work primarily focuses on identifying and developing standardized, high-quality botanical raw materials and active pharmaceutical ingredients for use in clinical trials. By leveraging their unique regulatory position, BRC supports the development of novel treatments for indications such as chronic pain and neurological conditions.